FdaApplication

NDA 212839

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSK LIFE SCIENCE INC
application_typeNDA
approval_date2020-03-10

Products (6)

ProductActive ingredientStrengthDosage form
XCOPRICENOBAMATE150MGTABLET;ORAL
XCOPRICENOBAMATE200MGTABLET;ORAL
XCOPRICENOBAMATE12.5MGTABLET;ORAL
XCOPRICENOBAMATE100MGTABLET;ORAL
XCOPRICENOBAMATE50MGTABLET;ORAL
XCOPRICENOBAMATE25MGTABLET;ORAL

6 products